5 Reasons Alnylam's Still a Top Biotech Stock to Buy Now - The Motley Fool | ALNY Message Board Posts


Alnylam Pharmaceuticals

  ALNY website

ALNY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34982 of 34998  at  7/1/2021 6:07:52 PM  by

jonzo13


5 Reasons Alnylam's Still a Top Biotech Stock to Buy Now - The Motley Fool

"Four global new drug approvals since 2018 is an impressive achievement, but Alnylam isn't done giving investors reasons to cheer. In fact, vutisiran is one of eight potential new drugs in the company's clinical-stage pipeline.  Alnylam also boasts dozens of programs in pre-clinical stages with plans to move them into trials with real people at a rate of two to four per year. With plenty of new drugs barreling through the pipeline, this is a terrific biotech stock to buy now and hold for at least another decade."


https://www.fool.com/investing/2021/07/01/5-reasons-alnylams-still-a-top-biotech-stock-to-bu/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0  
   Views: 0 [4]
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34983 Re: 5 Reasons Alnylam's Still a Top Biotech Stock to Buy Now - The Motley Fool Steve_382 0 7/1/2021 11:39:14 PM
34985 Re: 5 Reasons Alnylam's Still a Top Biotech Stock to Buy Now - The Motley Fool arthurs1 0 8/5/2021 3:08:07 PM


Financial Market Data provided by
.
Loading...